According to the Speciale Invest report titled 'The Indian Deep Tech Revolution: From Lab to Growth and Market Entry,' deep tech companies in India attracted $914 million across 257 rounds in 2025, a 34-fold increase compared to 2016. However, a more complex challenge lies in transforming scientific developments and prototypes into commercially viable products.
The study, based on Tracxn data as of August 31, 2026, covered 8,293 private companies globally, including 482 from India. In 2025, India accounted for 12.8% of the total deep tech funding rounds but received only 1.6% of the capital raised.
Analyzing seed funding rounds in India showed 23 Series A or B rounds for every 100 rounds, compared to 105 such rounds globally. Furthermore, for every 100 Indian seed funding rounds, there was one late-stage or venture capital round, whereas globally there were 26 such rounds per 100.
These figures indicate a decrease in funding intensity as companies mature. Sectoral advantages are unevenly distributed: aerospace firms can utilize ISRO test ranges and suppliers, while life sciences enterprises can rely on India's pharmaceutical manufacturing base. Since the 2020 reforms, private participation in space has increased, and the number of registered space startups grew from one in 2014 to approximately 440 by August 2026.
Skyroot's 'Vikram-I' in July became the first private Indian launch vehicle to reach orbit from Indian territory. While this is a significant milestone, a single launch does not guarantee the creation of a reproducible commercial business.
The report also notes that battery manufacturers still depend on imported cells and materials. It is worth mentioning that Exide launched the first phase of a 6 GWh cell manufacturing plant in Bengaluru in September. Semiconductor developers continue to rely on foreign production and packaging. The Semicon 2.0 program, approved in July with a budget of ₹1,275 crore, aims to expand domestic capacity, with the first factory planned for 2028.
A six-year R&D and innovation scheme worth ₹1 lakh crore is intended to fund high-risk technologies. By July 2026, the Technology Council had approved 22 projects with support totaling ₹2,192 crore. Assistance is provided mainly through long-term low-interest loans, equity, and equity-linked instruments, rather than standard grants.
Turning a successful pilot project or client trial into a full-fledged order remains a challenge. Vishvesh Rajaram, Managing Partner at Speciale Invest, emphasized that large corporations and public sector buyers can help transition from trials to commercial orders if they pre-agree on what the pilot must prove and when the purchase decision will be made. The first order allows a startup to plan production and sign supplier contracts.
Growth capital is also smaller. According to Vishnu Rajiv, Investment Partner at Speciale Invest, the average size of Series A and B rounds in India from January to August 2026 was $11.5 million, compared to $55.5 million globally.
Rajiv added that this gap is significant when a founder needs to qualify a product with a major client or order a production line before predictable commercial revenue is achieved. He believes that funding should align with the costs of achieving milestones, and project financing should occur after clients provide firm commitments.
The report calls for accelerating funding decisions, creating shared testing grounds, increasing the number of domestic Series B and C investors, and ensuring production financing before pilot projects are completed. Market exit options such as listings, acquisitions, licensing, and secondary stock sales are also being considered. In conclusion, deep tech requires not only research funds but also reliable customers and patient capital for growth.



